06-Sep-2019 By Melissa Fassbender, Outsourcing Pharma
Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space – with diagnostics also continuing to play a more important role in the market.
- Winner Takes All New Medicines
- The Rise of Diagnostic Testing
- A Sifting Balance of Power
- CRO Disruption
